Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.

Fast Breaking Comments

By Alexander Y. Rudensky

ESI Special Topics, April 2006
Citing URL - http://www.esi-topics.com/fbp/2006/april06-AlexanderYRudensky.html

Alexander Y. Rudensky answers a few questions about this month's fast breaking paper in the field of Immunology.


From •>>April 2006

Field: Immunology
Article Title: A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3
Authors: Fontenot, JD;Rudensky, AY
Journal: NAT IMMUNOL
Volume: 6
Issue: 4
Page: 331-337
Year: APR 2005
* Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.
* Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.
* Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA.

ST:  Why do you think your paper is highly cited?


“This review paper describes a central role transcription factor Foxp3 plays in development and function of a crucial subset of T cells...”

This is a review paper in one of the "super-hot" areas of immunology, and our laboratory has recently made significant contributions to this field. This particular field is both of fundamental interest and is also important for clinically relevant studies.

ST:  Does it describe a new discovery or a new methodology that’s useful to others?

This review paper describes a central role transcription factor Foxp3 plays in the development and function of a crucial subset of T cells—so-called regulatory T cells—controlling autoimmunity, anti-tumor immunity, and immunity to infections. A series of studies performed in the laboratory by Jason Fontenot established a role for Foxp3 as regulatory T cell lineage specification factor and provided definitive answers to several outstanding issues in the field.

Most importantly, these studies unequivocally demonstrated that lack of regulatory T cells results in an early onset, highly aggressive, and fatal autoimmune pathology affecting multiple organs.

ST:  Could you summarize the significance of your paper in layman's terms?

This review paper describes a central role transcription factor Foxp3 plays in development and function of a crucial subset of T cells controlling autoimmunity, anti-tumor immunity, and immunity to infections.

ST:  How did you become involved in this research, and were any problems encountered along the way?

Our interest in regulatory T cell biology can be traced to a journal club on "historic papers" in immunology organized by first-year graduate students in the department. A heated discussion in one of these journal clubs discussing early work of Sir Peter Medawar* on neonatal tolerance precipitated our thinking and interest in the problem of "dominant tolerance".

It also coincided with Marc Gavin joining the lab at that time as a postdoctoral fellow and Marc was very interested in starting a new project on regulatory T cells. Another major event was identification of transcription factor Foxp3 by Fred Ramsdell and colleagues at the Bothell, Washington-based firm Celltech, who greatly helped us to jump-start Foxp3-related research.

The main problem we encountered was the very intense competition the massive amount of publication in these areas which resulted in a flood of data of varying quality being published in a rush.End

Alexander Rudensky, Ph.D.
Professor, Department of Immunology, University of Washington 
Investigator, Howard Hughes Medical Institute
University of Washington School of Medicine
Seattle, WA, USA

*Sir Peter Brian Medawar (February 28, 1915—October 2, 1987) was a Brazilian-born English scientist best known for his work on how the immune system rejects or accepts organ transplants. He was co-winner of the 1960 Nobel Prize in Physiology or Medicine with Sir Frank Macfarlane Burnet.

ESI Special Topics, April 2006
Citing URL - http://www.esi-topics.com/fbp/2006/april06-AlexanderYRudensky.html

•> Search Special Topics
Fast Breaking Papers Menu || All Topics Menu
Fast Breaking Papers Comments Menu
Help || About || Contact

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.